John T. Treace is CEO at TREACE MEDICAL CONCEPTS, INC. (TMCI). They have made 25 open-market trades across 1 company since 2021, most recently 2026-08-24.
CIK 0001856380
18 open-market purchases totalling $9.3M since 2022, against 7 sales. Across 17 scored buys the stock is up 12.7% at ninety days, and 10.3 points ahead of the S&P over the same stretch.
18 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| TMCI | 7,404,383 | $28.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 61% | 78% | 71% |
| Avg Move | +2.9% | +9.2% | +12.7% |
| Alpha | +3.2% | +10.5% | +10.3% |
| Scored | 18 | 18 | 17 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMCI | BUY | 2026-08-20 | 2026-08-24 | $4.41 | $247K | +3.2% | -4.5% | — |
| TMCI | BUY | 2026-06-10 | 2026-06-12 | $4.03 | $99K | +12.8% | +16.2% | +10.4% |
| TMCI | BUY | 2026-06-10 | 2026-06-11 | $4.03 | $211K | -1.7% | +9.0% | +7.9% |
| TMCI | BUY | 2026-06-01 | 2026-06-01 | $3.56 | $178K | +4.3% | +13.0% | +25.9% |
| TMCI | BUY | 2026-05-26 | 2026-05-28 | $2.95 | $341K | +11.3% | +27.5% | +41.2% |
| TMCI | BUY | 2026-05-12 | 2026-05-14 | $2.44 | $376K | +1.8% | +37.5% | +66.5% |
| TMCI | BUY | 2025-03-04 | 2025-03-04 | $8.73 | $524K | -15.1% | -16.3% | -38.7% |
| TMCI | BUY | 2024-09-16 | 2024-09-17 | $5.31 | $266K | +5.9% | -2.9% | +39.3% |
| TMCI | BUY | 2024-08-14 | 2024-08-15 | $6.00 | $510K | -2.8% | -20.7% | +25.3% |
| TMCI | BUY | 2024-06-11 | 2024-06-11 | $5.88 | $265K | -8.5% | +29.2% | -18.0% |
| TMCI | BUY | 2024-05-17 | 2024-05-20 | $5.56 | $556K | +8.9% | +8.5% | +18.1% |
| TMCI | BUY | 2024-05-14 | 2024-05-14 | $5.12 | $768K | -10.6% | +4.0% | -1.4% |
| TMCI | BUY | 2024-05-10 | 2024-05-13 | $4.57 | $2.1M | -1.0% | +19.3% | +11.8% |
| TMCI | SELL | 2023-03-09 | 2023-03-10 | $24.41 | $101K | +0.3% | +15.6% | +9.2% |
| TMCI | BUY | 2022-11-21 | 2022-11-21 | $21.83 | $327K | +6.0% | +5.7% | -3.3% |
| TMCI | BUY | 2022-11-17 | 2022-11-17 | $21.67 | $433K | +3.1% | +1.9% | -2.8% |
| TMCI | BUY | 2022-09-01 | 2022-09-01 | $19.80 | $198K | +20.7% | +14.0% | +15.5% |
| TMCI | BUY | 2022-08-26 | 2022-08-29 | $20.95 | $900K | +16.8% | +13.7% | +10.0% |
| TMCI | BUY | 2022-08-23 | 2022-08-24 | $18.72 | $1.1M | -3.2% | +10.1% | +8.1% |
| TMCI | SELL | 2021-12-28 | 2021-12-30 | $16.99 | $776K | +11.1% | -1.5% | +2.7% |
| TMCI | SELL | 2021-12-22 | 2021-12-27 | $16.72 | $2.7M | +3.3% | +4.1% | +9.5% |
| TMCI | SELL | 2021-12-20 | 2021-12-22 | $15.98 | $1.9M | +20.0% | +11.4% | +19.8% |
| TMCI | SELL | 2021-11-22 | 2021-11-24 | $17.84 | $5.3M | +3.2% | -0.6% | +9.0% |
| TMCI | SELL | 2021-10-20 | 2021-10-22 | $21.54 | $7.1M | +9.6% | -17.5% | -10.8% |
| TMCI | SELL | 2021-04-27 | 2021-04-29 | $17.00 | $89.3M | +11.7% | +15.0% | -2.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.